NCT04758247View on ClinicalTrials.gov

Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

December 8, 2023

Study Completion Date

December 8, 2023

Conditions

Overactive Bladder

Interventions

DEVICE

TheraNova Neuromodulation System

The investigational device is a transcutaneous electrical nerve stimulation (TENS) device that is designed to provide stimulation to the nerves at the site of application via surface electrodes temporarily adhered to the skin.

Trial Locations (2)

94305

Stanford Medicine, Stanford

95817

UC Davis Health, Sacramento

All Listed Sponsors

lead

Theranova, L.L.C.

INDUSTRY

NCT04758247 - Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms | Biotech Hunter | Biotech Hunter